Precipio, Inc - PRPO Net Assets per Single Share

The visualization of book value per share demonstrates the impact of insurance limits on test costs. Proprietary consumables and recurring revenue ensure business stability. Precipio, Inc. generates revenue from expert blood analyses for oncology clinics. The value of 8.32 shapes the current metric, allowing for a real-time assessment of the actual capital of Precipio, Inc. net of all liabilities.

Precipio Inc. (PRPO) - Accounting Value per Share from 07/04/2022 to 10/26/2026

Summary analytical data breakdowns for precipiodx.com (PRPO)

- price and consensus price forecast:

Price Chart Precipio, Inc|PRPO - Forecast Levels Chart

- market capitalization data:

Market Value Precipio, Inc.|PRPO - Total Enterprise Value

- book capitalization data:

Book Value per Share Precipio|PRPO - Company Net Assets|Market Capitalization to Book Value Ratio precipiodx.com|PRPO - Company Total Assets

- debt and liquidity data:

Debt to Equity Precipio, Inc.|PRPO - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital Precipio|PRPO - Company Total Debt|Debts to Book Capitalization Precipio, Inc.

Analysis of all company metrics:Precipio, Inc, PRPO

Investors are evaluating the potential of Precipio, Inc. (PRPO) through the price-to-book ratio, where the book value per share reflects the portion of equity attributable to a single security after deducting all liabilities. By analyzing this chart of historical book value per share, one can determine how effectively investments in the precision cancer genetic diagnostics platform are being capitalized into actual business value.

Competitor analysis for Precipio, Inc.